STRONGID C PREMIX DIN 02046717
Status: Cancelled Post Market
Holder: PFIZER CANADA INC ANIMAL HEALTH GROUP
Molecule: PYRANTEL TARTRATE
Health Canada record
| Active ingredient(s) | PYRANTEL TARTRATE 10.6 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Oct-1996 |
| Current status date | 15-Jul-2003 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PYRANTEL TARTRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00491799 | PRO-BANMINTH | PHIBRO ANIMAL HEALTH CORPORATION | Drug Premix | PYRANTEL TARTRATE 106 G | Marketed |
| 02008084 | PREMELANGE 25/2 PORCS MEDICAMENTE (PRO-BAN.) | LA COOP FEDEREE | Drug Premix | PYRANTEL TARTRATE 8.48 G | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 6596 | 1999-07-06 | New Drug Submission (NDS) |
International API supply for PYRANTEL TARTRATE
2 active FDA Drug Master Files.
Request a quote for STRONGID C PREMIX